MOLECULAR-GENETIC FACTORS, ASSOCIATED WITH AORTIC STENOSIS DEVELOPMENT
Aortic stenosis (AS) is one of the most prevalent valvular heart disorders in patients older than 65 years. Regardless the studied molecular mechanisms of development and progression of the disease, surgical treatment is recently the only successful method of help. Due to lots of comorbidities of ol...
Saved in:
Main Authors: | T. A. Tipteva, O. S. Chumakova, D. A. Zateyshchikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2015-10-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/325 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GENETIC MARKERS OF MYOCARDIAL FIBROSIS: OPPORTUNITY TO PREDICT ADVERSE OUTCOMES IN AORTIC STENOSIS
by: Т. A. Tipteva, et al.
Published: (2018-03-01) -
From Aortic Stenosis to Cardiomyopathy
by: Muhammad Salman Sabri, MD, et al.
Published: (2025-07-01) -
Discordant High-Gradient Aortic Stenosis: A Systematic Review
by: Nadera N. Bismee, et al.
Published: (2025-07-01) -
Hereditary mechanisms in the development of sclerotic degenerative disorders of aortic valve
by: N. N. Parfenova, et al.
Published: (2013-02-01) -
"They are closely interconnected, complement each other and pass into each other, there are no clear boundaries between them". Case report
by: E. A. Rogozhkina, et al.
Published: (2023-06-01)